She suffered from Sjogren syndrome and inflammatory arthritis and was currently treated with prednisone and methotrexate. She was previously treated with hydroxychloroquine (Plaquenil) 200mg bid (6.5mg/kg) for 10 years, which was stopped one year prior to presentation. P falciparum resistance to chloroquine Malaria tablets chloroquine Is p falciparum chloroquine resistant Diagnosis Hydroxychloroquine-induced retinal toxicity Discussion. Chloroquine CQ and hydroxychloroquine Plaquenil HCQ have been used for many years, initially for the treatment of malaria but now more commonly for the treatment of inflammatory diseases such as rheumatoid arthritis and lupus 1. Abstract. Background The American Academy of Ophthalmology recommendations on screening for chloroquine CQ and hydroxychloroquine HCQ retinopathy are revised in light of new information about the prevalence of toxicity, risk factors, fundus distribution, and effectiveness of screening tools. Background/Purpose Hydroxychloroquine HCQ induced retinal toxicity remains a major concern because it can lead to irreversible damage to retinal pigment epithelium and blindness. American Academy of Ophthalmology AAO 2016 guidelines recommend to use HCQ at dosages ≤5 mg/kg real body weight to minimize toxicity 1. Review of systems: Blurred vision, halos, dry eye, dry mouth, gastroesophageal reflux, joint pain Pupils: Reactive to light in each eye from 5 mm in the dark to 2 mm in the light. Extraocular movements: Full, both eyes (OU) Confrontation visual fields: Full OU Intra-ocular pressure The optic nerves appeared healthy with a 0.3 cup-to-disc ratio. Past Ocular History: None Medical History: Sjogren syndrome and inflammatory arthritis, supraventricular tachycardia, anxiety, depression, peptic ulcer disease Medications: prednisone, methotrexate, amitriptyline, ranitidine, estradiol, tizanidine, diltiazem, Restasis Allergies: codeine, droperidol Family History: heart disease, arthritis, cancer Social History: occasional alcohol but no tobacco or intravenous drug use. Hydroxychloroquine american academy of ophthalmology Adherence Patterns to American Academy of Ophthalmology., Recommendations on Screening for Chloroquine and. Plaquenil side effects acnePsoriasis plaquenilPlaquenil sun sensitivityPlaquenil and probiotics Background/Purpose Hydroxychloroquine is universally recommended to treat patients with SLE, stressing the importance of appropriate dosing. The 2016 American Academy of Ophthalmology AAO guidelines recommend a maximum dose of hydroxychloroquine ≤ 5mg/kg/day actual body weight ABW,1 which correlates more with retinal toxicity risks than using ideal body weight to calculate dosage. We. Hydroxychloroquine Do We All See Eye to Eye? a Single-Site.. Compliance with Hydroxychloroquine Dosage According to 2016.. New American Academy of Ophthalmology recommendations on.. Ophthalmology. 2011 Oct;118102100; author reply 2101. BACKGROUND The American Academy of Ophthalmology recommendations for screening of chloroquine CQ and hydroxychloroquine HCQ retinopathy were published in 2002, but improved screening tools and new knowledge about the prevalence of toxicity have appeared in the ensuing years. Baseline examination for all patients treated with hydroxychloroquine recommended by the American Academy of Ophthalmology AAO In summary, despite the limitations of the study by Almony et al, TAG may be a more sensitive means for detecting subtle scotomas in patients taking HCQ. Academy CEO, David Parke, MD, presents a perspective in EyeNet EyeWiki, Do you Wiki? 2020 International Ophthalmologists contest is now open. Contribute to EyeWiki before June 2, 2020, for a chance to win online products from the Academy. Winners will also be considered for presenting their work at the AAO Annual Meeting.